Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU7-80P (RNA, U7 small nuclear 80 pseudogene) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but is generally considered nonfunctional; it does not encode a functional product and has no established biological function, involvement in disease, or interactions with drugs. It is a presumed non-functional copy closely related to genes coding for U7 small nuclear RNA, which in its active form (not as a pseudogene) is part of the U7 small nuclear ribonucleoprotein (snRNP) complex required for processing histone pre-mRNA[7]. There is no evidence that RNU7-80P is translated or used in therapeutic targeting, nor does it play an established role in human disease or physiology[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 80 pseudogene (RNU7-80P).